Human embryonic stem cell-derived mesenchymal stem cells repress liver fibrosis via enhancing of TIF1γ in mice : 인간배아줄기세포 유래 중배엽줄기세포의 생쥐에서 TIF1γ의 증가를 통한 간섬유화 억제

Cited 0 time in Web of Science Cited 0 time in Scopus


융합과학기술대학원 분자의학 및 바이오제약학과
Issue Date
서울대학교 융합과학기술대학원
liver fibrosishuman embryonic stem cell-derived mesenchymal stem cellshuman hepatic stellate cellsTIF1γhepatocyte growth factor
학위논문 (석사)-- 서울대학교 융합과학기술대학원 : 분자의학 및 바이오제약학과, 2015. 8. 김효수.
Progressive liver fibrosis leads to cirrhosis and liver failure and requires liver transplantation, which is often indicated as the only effective therapy. However, the limitations of liver transplantation are associated with organ shortages and long-term immunosuppression. Recent technological advances have led to the disclosure of cellular and molecular mechanisms underlying liver fibrosis and the development of prospective therapeutic approaches to reduce or reverse liver fibrosis, which would decrease the associated morbidity and demand for liver transplantation. In this study, we performed transplantation of human embryonic stem cell-derived mesenchymal stem cells (hE-MSCs) to the livers of thioacetamide (TAA)-treated mice. The result of histological analysis using Massons trichrome staining, which detects collagen fibers, showed the recovery of TAA-induced liver fibrosis at 14 and 21 days after transplantation of hE-MSCs. To address the underlying mechanism, we screened candidate anti-fibrotic factors and selected transcriptional intermediary factor 1 (TIF1)γ. Our results indicate that TIF1γ inhibited the activation of cultured human hepatic stellate cells (HSCs), as evidenced by the decrease of smooth muscle actin (α-SMA) and collagen type I. TIF1γ was downregulated by pro-fibrotic signals such as TAA and transforming growth factor (TGF)β1 and upregulated by hE-MSCs in vivo, suggesting that TIF1γ is an anti-fibrotic factor expressed in HSCs. Using fluorescent-labeled hE-MSCs, we observed that some of the transplanted hE-MSCs survived and trans-differentiated to HSCs and could secrete paracrine hepatocyte growth factor (HGF) in TAA-treated livers. The downregulation of TIF1γ and upregulation of α-SMA shown in experimental liver fibrosis were confirmed in human cirrhotic livers. Our findings suggest that TIF1γ is a potent anti-fibrotic factor, which can be utilized in the development of novel therapeutic approaches to prevent and reverse liver fibrosis.
Files in This Item:
Appears in Collections:
Graduate School of Convergence Science and Technology (융합과학기술대학원)Dept. of Molecular and Biopharmaceutical Sciences (분자의학 및 바이오제약학과)Theses (Master's Degree_분자의학 및 바이오제약학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.